• Education regarding H.R.6465-Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act) Issues related to the Medicaid Drug Rebate Program proposed rule, gene therapies, and value-based payment arrangements. Education on issues related to plasma derived products and inflation penalties related to drug shortages.

Duration: January 3, 2006 to present

General Issues: Health Issues, Taxation/Internal Revenue Code, Immigration, Government Issues, Trade (Domestic & Foreign), Medicare/Medicaid, Medical/Disease Research/Clinical Labs

Spending: about $11,030,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2006: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Homeland Security - Dept of (DHS), U.S. Customs & Border Protection, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Treasury - Dept of, Internal Revenue Service (IRS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)

Affiliated organizations: Alston & Bird LLP

Related Foreign Entities: CSL Limited (Parkville, Victoria, AUS); contribution to lobbying: $0; ownership 100%